LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 51

Search options

  1. Article ; Online: Morphological Harbingers of ARMC5-Pathogenic Variant-Related Bilateral Macronodular Adrenocortical Disease.

    de Arruda Botelho, Maria Luiza Anhaia / Nishi, Mirian Yumie / Ribeiro, Karina Braga / Zerbini, Maria Claudia Nogueira

    Endocrine pathology

    2023  Volume 34, Issue 2, Page(s) 200–212

    Abstract: Bilateral macronodular adrenocortical disease (BMAD) is a neoplastic disease associated with a high frequency of germline disease. Armadillo repeat containing 5 (ARMC5) pathogenic variants (PVs) have not been widely studied to determine the morphological ...

    Abstract Bilateral macronodular adrenocortical disease (BMAD) is a neoplastic disease associated with a high frequency of germline disease. Armadillo repeat containing 5 (ARMC5) pathogenic variants (PVs) have not been widely studied to determine the morphological and immunohistochemical characteristics of BMAD. We carried out a detailed morphologic review of 22 surgical specimens excised from patients with BMAD and compared them with PV of ARMC5 (PV + , n = 14) and those without (PV - , n = 8), and further comparing them with a control group of adrenals excised from patients with renal cancer (n = 11). No patients presented with a genetic syndrome related to BMAD. Overt Cushing's syndrome was present in 12/22 patients, 10 PV + and 2 PV - (p = 0.074). We also evaluated the expression of Ki-67, BCL-2, BAX, p53, CYP11B1, and ARMC5 protein. The pseudo-glandular and trabecular architectural patterns were strongly associated with the PV + group (both p < 0.001), as well as capsular extrusion (p < 0.001). There was no predictive value in the distinction of ARMC5 variants in Hsiao subtyping. ARMC5 diffuse cytoplasmic staining was observed in all 11 control samples. The ARMC5 expression was significantly lower in BMAD than in the control group (p < 0.001). In all the specimens, expression of BCL-2 was identified only in the medulla, and expression of BAX was observed in adrenocortical cells. CYP11B1 diffuse immunoexpression was identified in all the specimens of BMAD and in the fasciculata zone in the control group. The mitotic count and Ki-67 proliferation index was very low in all three groups (controls, PV + , and PV - BMAD). None of the specimens stained positive for the p53 protein. Although our series is limited, the presence of pseudo-glandular and/or trabecular patterns and capsular extrusion indicated the presence of pathogenic variants of ARMC5 in BMAD. The gland enlargement does not seem to be related to the increase of mitotic count or a higher proliferation index (Ki-67).
    MeSH term(s) Humans ; Tumor Suppressor Protein p53 ; Steroid 11-beta-Hydroxylase ; Ki-67 Antigen ; bcl-2-Associated X Protein ; Tumor Suppressor Proteins/genetics ; Hyperplasia ; Armadillo Domain Proteins/genetics
    Chemical Substances Tumor Suppressor Protein p53 ; Steroid 11-beta-Hydroxylase (EC 1.14.15.4) ; Ki-67 Antigen ; bcl-2-Associated X Protein ; Tumor Suppressor Proteins ; ARMC5 protein, human ; Armadillo Domain Proteins
    Language English
    Publishing date 2023-04-12
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1033267-4
    ISSN 1559-0097 ; 1046-3976
    ISSN (online) 1559-0097
    ISSN 1046-3976
    DOI 10.1007/s12022-023-09761-5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Dr. Dorfman legacy to pathology: beyond Rosai-Dorfman disease.

    Zerbini, Maria Claudia Nogueira

    Autopsy & case reports

    2013  Volume 3, Issue 1, Page(s) 1–4

    Language English
    Publishing date 2013-03-31
    Publishing country Brazil
    Document type Editorial
    ZDB-ID 2815488-5
    ISSN 2236-1960
    ISSN 2236-1960
    DOI 10.4322/acr.2013.001
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Bildgesteuerte Lymphknoten-Kernnadelbiopsie bei Mycosis fungoides/Sézary-Syndrom: Direkter Vergleich zur chirurgischen Exzision.

    Cury-Martins, Jade / Netto, Sérgio Dias do Couto / de Castro, Stephanie Catarine Carqueijo / Siqueira, Sheila Aparecida Coelho / Giannotti, Marcelo Abrantes / Zerbini, Maria Claudia Nogueira / Pereira, Juliana / Culler, Hebert / Teixeira, Frederico José Ribeiro / de Menezes, Marcos Roberto / Sanches, José Antônio

    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

    2022  Volume 20, Issue 7, Page(s) 1008–1010

    Language English
    Publishing date 2022-07-25
    Publishing country Germany
    Document type Letter
    ZDB-ID 2093479-8
    ISSN 1610-0387 ; 1610-0379
    ISSN (online) 1610-0387
    ISSN 1610-0379
    DOI 10.1111/ddg.14774_g
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Image-guided lymph node core needle biopsy in mycosis fungoides/Sézary syndrome: Direct comparison to surgical excision.

    Cury-Martins, Jade / Netto, Sérgio Dias do Couto / de Castro, Stephanie Catarine Carqueijo / Siqueira, Sheila Aparecida Coelho / Giannotti, Marcelo Abrantes / Zerbini, Maria Claudia Nogueira / Pereira, Juliana / Culler, Hebert / Teixeira, Frederico José Ribeiro / de Menezes, Marcos Roberto / Sanches, José Antônio

    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

    2022  Volume 20, Issue 7, Page(s) 1008–1010

    MeSH term(s) Biopsy, Large-Core Needle ; Humans ; Lymph Nodes/pathology ; Lymphoma, T-Cell, Cutaneous/pathology ; Mycosis Fungoides/pathology ; Mycosis Fungoides/surgery ; Sezary Syndrome/surgery ; Skin Neoplasms/pathology ; Skin Neoplasms/surgery
    Language English
    Publishing date 2022-06-07
    Publishing country Germany
    Document type Letter ; Comment
    ZDB-ID 2093479-8
    ISSN 1610-0387 ; 1610-0379
    ISSN (online) 1610-0387
    ISSN 1610-0379
    DOI 10.1111/ddg.14774
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: TET-2 mutations predict poor outcomes and are associated with unfavorable clinical-biological features in PTCL, not otherwise specified and angioimmunoblastic T-cell lymphoma in Brazilian patients.

    de Pádua Covas Lage, Luís Alberto / Barreto, Guilherme Carneiro / Culler, Hebert Fabricio / Cavalcante, Jéssica Billar / de Oliveira Alves, Lucas Bassolli / Nardinelli, Luciana / Bendit, Israel / Zerbini, Maria Cláudia Nogueira / Rocha, Vanderson / Pereira, Juliana

    Cancer biomarkers : section A of Disease markers

    2022  Volume 35, Issue 2, Page(s) 179–191

    Abstract: Introduction: Nodal peripheral T-cell lymphomas [nPTCL] constitute a heterogeneous group of rare malignancies with aggressive biological behavior and poor prognosis. Epigenetic phenomena involving genes that control DNA-methylation and histone ... ...

    Abstract Introduction: Nodal peripheral T-cell lymphomas [nPTCL] constitute a heterogeneous group of rare malignancies with aggressive biological behavior and poor prognosis. Epigenetic phenomena involving genes that control DNA-methylation and histone deacetylation play a central role in their pathogenesis. However, the mutational landscape involving epigenetic regulators has never been reported in Latin American patients and their prognostic impact remains controversial.
    Patients and methods: From 2000 to 2019, 59-Brazilian patients with nPTCL were eligible for screening mutations in the IDH-1, IDH-2, RHOA, TET-2 and DNMT3A genes by Sanger sequencing at Formalin-Fixed Paraffin-Embedded samples [FFPE] of diagnosis. We reported the frequency, distribution and potential prognosis of these mutations.
    Results: With a median follow-up of 3.70 years, estimate 2-year OS and PFS were 57.1% and 49.2%, respectively. Mutations in the IDH-1 gene were not found, mutations in the IDH-2 occurred in 3.4% (2/59), RHOA in 23.7% (14/59), TET-2 in 50.8% (30/59) and DNMT3A in 62.7% (37/59). RHOA gene mutations were more frequent in PTCL, NOS and AITL (p= 0.06). Almost half of the patients had more than one mutation in concomitance, particularly RHOA-mut and TET-2-mut. Mutations in RHOA (p= 0.030) and TET-2 (p= 0.046) were associated with high-tumor burden. In the non-ALCL subgroup (PTCL, NOS and AITL) TET-2 mutations were associated with decreased 2-year PFS [HR: 2.22, p= 0.048]. Likewise with lower overall response rate [ORR] (p= 0.048) and unfavorable clinical features, as bulky disease (p= 0.012), ECOG ⩾ 2 (p= 0.032), B-symptoms (p= 0.012), ⩾ 2 extranodal sites compromised (p= 0.022) and high-risk Prognostic Index for T-cell lymphoma (p= 0.005).
    Conclusion: Mutations in RHOA, TET-2 and DNMT3A were frequent in Brazilian patients with nPTCL. TET-2 mutations were associated with lower ORR for CHOP-like chemotherapy, decreased PFS and unfavorable clinical-biological characteristics in non-ALCL (PTCL, NOS and AITL). Further studies using a larger cohort may validate our findings.
    MeSH term(s) Humans ; Brazil/epidemiology ; DNA ; Formaldehyde ; Histones ; Immunoblastic Lymphadenopathy/genetics ; Immunoblastic Lymphadenopathy/pathology ; Lymphoma, T-Cell/diagnosis ; Lymphoma, T-Cell/genetics ; Lymphoma, T-Cell/pathology ; Lymphoma, T-Cell, Peripheral/genetics ; Lymphoma, T-Cell, Peripheral/pathology ; Mutation ; Prognosis
    Chemical Substances DNA (9007-49-2) ; Formaldehyde (1HG84L3525) ; Histones ; TET2 protein, human (EC 1.13.11.-)
    Language English
    Publishing date 2022-10-24
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 2203517-5
    ISSN 1875-8592 ; 1574-0153 ; 1875-8592
    ISSN (online) 1875-8592 ; 1574-0153
    ISSN 1875-8592
    DOI 10.3233/CBM-220013
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Up-front Therapy With CHOP Plus Etoposide in Brazilian nodal PTCL Patients: Increased Toxicity and No Survival Benefit Compared to CHOP Regimen-Results of a Real-Life Study From a Middle-Income Country.

    Lage, Luís Alberto de Pádua Covas / Brito, Cláudio Vinícius / Barreto, Guilherme Carneiro / Culler, Hebert Fabrício / Reichert, Cadiele Oliana / Levy, Débora / Costa, Renata de Oliveira / Zerbini, Maria Cláudia Nogueira / Rocha, Vanderson / Pereira, Juliana

    Clinical lymphoma, myeloma & leukemia

    2022  Volume 22, Issue 11, Page(s) 812–824

    Abstract: Background: Nodal peripheral T-cell lymphoma (nPTCL) constitute a heterogeneous group of neoplasms with aggressive behavior and poor-survival. They are more prevalent in Latin America and Asia, although data from Brazil are scarce. Its primary therapy ... ...

    Abstract Background: Nodal peripheral T-cell lymphoma (nPTCL) constitute a heterogeneous group of neoplasms with aggressive behavior and poor-survival. They are more prevalent in Latin America and Asia, although data from Brazil are scarce. Its primary therapy is still controversial and ineffective. Therefore, we aim to describe clinical-epidemiological characteristics, outcomes, predictors factors for survival and compare the results of patients treated with CHOP and CHOEP regimens.
    Methods: Retrospective, observational and single-center study involving 124 nPTCL patients from Brazil treated from 2000 to 2019.
    Results: With a median follow-up of 23.7 months, the estimated 2-year overall survival (OS) and progression-free survival (PFS) were 59.2% and 37.3%, respectively. The median age was 48.5 years and 57.3% (71/124) were male, 81.5% (101/124) had B-symptoms, 88.7% (110/124) had advanced disease (stage III/IV) and 58.1% (72/124) presented International Prognostic Index (IPI) score ≥3, reflecting a real-life cohort. ORR to first-line therapy was 58.9%, 37.9% (N = 47) received CHOP-21 and 35.5% (N = 44) were treated with CHOEP-21; 30.1% (37/124) underwent to consolidation with involved field radiotherapy (IF-RT) and 32.3% (40/124) were consolidated with autologous hematopoietic stem cell transplantation (ASCT). The overall response rate (ORR) was similar for CHOP-21 (76.6%) and CHOEP-21 (65.9%), P = .259. Refractory disease was less frequent in the CHOEP-21 group (4.5% vs. 21.2%, P = .018). However, few patients were able to complete 6-cycles of CHOEP-21 (31.8%) than to CHOP-21 (61.7%), P = .003. Delays ≥2 weeks among the cycles of chemotherapy were more frequent for patients receiving CHOEP-21 (43.1% vs. 10.6%), P = .0004, as well as the toxicities, including G3-4 neutropenia (88% vs. 57%, P = .001), febrile neutropenia (70% vs. 38%, P = .003) and G3-4 thrombocytopenia (63% vs. 27%, P = .0007). The 2-year OS was higher for CHOP (78.7%) than CHOEP group (61.4%), P = .05, as well as 2-year PFS (69.7% vs. 25.0%, P < .0001). In multivariate analysis, high LDH (HR 3.38, P = .007) was associated with decreased OS. CR at first line (HR: 0.09, P < .001) and consolidation with ASCT (HR: 0.08, P = .015) were predictors of increased OS.
    Conclusion: In the largest cohort of nPTCL from Latin America, patients had poor survival and high rate of chemo-resistance. In our cohort, the addition of etoposide to the CHOP-21 backbone showed no survival benefit and was associated with high-toxicity and frequent treatment interruptions. Normal LDH values, obtaintion of CR and consolidation with ASCT were independent factors associated with better outcomes.
    MeSH term(s) Humans ; Male ; Middle Aged ; Female ; Etoposide ; Brazil/epidemiology ; Retrospective Studies ; Vincristine/adverse effects ; Cyclophosphamide/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Prednisone/adverse effects ; Doxorubicin/adverse effects ; Prednisolone/therapeutic use ; Lymphoma, T-Cell, Peripheral/pathology
    Chemical Substances Etoposide (6PLQ3CP4P3) ; Vincristine (5J49Q6B70F) ; Cyclophosphamide (8N3DW7272P) ; Prednisone (VB0R961HZT) ; Doxorubicin (80168379AG) ; Prednisolone (9PHQ9Y1OLM)
    Language English
    Publishing date 2022-06-29
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2540992-X
    ISSN 2152-2669 ; 2152-2650
    ISSN (online) 2152-2669
    ISSN 2152-2650
    DOI 10.1016/j.clml.2022.06.012
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Metastatic congenital neuroblastoma associated with in situ neuroblastoma: case report and review of literature.

    Costa, Andressa Dias / Zerbini, Maria Claudia Nogueira / Cristofani, Lilian

    Autopsy & case reports

    2014  Volume 4, Issue 2, Page(s) 27–33

    Abstract: Although neonatal tumors are rare, neuroblastoma is the most common neoplasia among them. These tumors, which usually involve children in early infancy, are derived from neural crest cells of adrenal gland medulla or sympathetic ganglia. Even though ... ...

    Abstract Although neonatal tumors are rare, neuroblastoma is the most common neoplasia among them. These tumors, which usually involve children in early infancy, are derived from neural crest cells of adrenal gland medulla or sympathetic ganglia. Even though congenital metastatic neuroblastoma presents a favorable prognosis, it may lead to death if not recognized and treated early on. The authors report the case of a 2-month-old child who was born from in vitro fertilization, and whose diagnosis was made after birth. The form of presentation of this case as a metastatic disease concerning this age group is noteworthy.
    Language English
    Publishing date 2014-06-30
    Publishing country Brazil
    Document type Case Reports
    ZDB-ID 2815488-5
    ISSN 2236-1960
    ISSN 2236-1960
    DOI 10.4322/acr.2014.017
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: The role of whole-brain radiotherapy (WBRT) in primary central nervous system lymphoma: is it an alternative to ASCT for consolidation following HD-methotrexate based induction in low-income settings?

    de Pádua Covas Lage, Luís Alberto / Araújo Soares, Vinícius / Meneguin, Thales Dalessandro / Culler, Hebert Fabrício / Reichert, Cadiele Oliana / Jacomassi, Mayara D'Auria / Reis, Diego Gomes Cândido / Zerbini, Maria Cláudia Nogueira / de Oliveira Costa, Renata / Rocha, Vanderson / Pereira, Juliana

    Radiation oncology (London, England)

    2022  Volume 17, Issue 1, Page(s) 171

    Abstract: Background: Primary central nervous system lymphoma (PCNSL) is a rare and aggressive malignancy. Although potentially curable, its prognosis remains dismal. Its treatment is based on high-doses of methotrexate (HD-MTX) and rituximab, followed by ... ...

    Abstract Background: Primary central nervous system lymphoma (PCNSL) is a rare and aggressive malignancy. Although potentially curable, its prognosis remains dismal. Its treatment is based on high-doses of methotrexate (HD-MTX) and rituximab, followed by consolidation therapy with whole-brain radiotherapy (WBRT) or autologous stem cell transplantation (ASCT). Currently, there is no consensus about the best consolidation strategy, but better outcomes with ASCT are obtained with conditioning regimens based on thiotepa, a high-cost drug with restricted use in resource-constrained settings. Latin American data on clinical outcomes, prognostic factors, and therapeutic management in PCNSL are virtually unknown.
    Methods: This is a retrospective, observational, and single-center study involving 47-Brazilian patients with PCNSL. We aim to assess outcomes, determine predictors of survival, and compare responses, as well as toxicities in patients consolidated with chemotherapy alone versus chemotherapy plus WBRT.
    Results: The median age at diagnosis was 59 years (24-88 years), and 53.1% were male. LDH ≥ UVN occurred in 44.7%, ECOG ≥ 2 in 67.6%, and 34.1% had multifocal disease. Hemiparesis was the main clinical presentation, observed in 55.3%, 51.0% had intermediate-/high-risk IELSG prognostic score, and 57.6% had an ABC-like phenotype by IHC. With a median follow-up of 24.4 months, estimated 5-year OS and PFS were 45.5% and 36.4%, respectively. Among 40 patients treated with HD-MTX-based induction, estimated 2-year OS was 85.8% for those consolidated with WBRT plus HIDAC versus only 41.5% for those consolidated with HIDAC alone (p < 0.001). Hematologic and non-hematologic toxicities were not significant, and severe cognitive impairment occurred in only 6.3% (3/47) of cases, all of them treated with WBRT. Age < 60 years, Hb ≥ 120 g/L and WBRT consolidation were associated with increased OS, however, LDH ≥ UVN, hypoalbuminemia, ECOG ≥ 2, Karnofsky PS < 70 and intermediate-/high-risk Barcelona score were associated with decreased OS.
    Conclusion: Combined consolidation therapy (CCT) based on WBRT plus HIDAC was associated with increased OS in PCNSL compared to isolated consolidation therapy (ICT) based on HIDAC alone. Here, severe late neurotoxicity was uncommon with this approach. These data suggest that WBRT may be an effective and safe alternative to ASCT for consolidation therapy in PCNSL, particularly in resource-constrained settings, where access to thiotepa for pre-ASCT conditioning is not universal.
    MeSH term(s) Male ; Female ; Humans ; Transplantation, Autologous ; Thiotepa/therapeutic use ; Methotrexate/therapeutic use ; Hematopoietic Stem Cell Transplantation ; Central Nervous System Neoplasms/drug therapy ; Central Nervous System Neoplasms/radiotherapy ; Rituximab/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols ; Stem Cell Transplantation/adverse effects ; Combined Modality Therapy ; Lymphoma ; Brain/pathology ; Central Nervous System/pathology
    Chemical Substances Thiotepa (905Z5W3GKH) ; Methotrexate (YL5FZ2Y5U1) ; Rituximab (4F4X42SYQ6)
    Language English
    Publishing date 2022-10-22
    Publishing country England
    Document type Observational Study ; Journal Article
    ZDB-ID 2224965-5
    ISSN 1748-717X ; 1748-717X
    ISSN (online) 1748-717X
    ISSN 1748-717X
    DOI 10.1186/s13014-022-02142-y
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Absolute monocyte count is a predictor of overall survival and progression-free survival in nodal peripheral T cell lymphoma.

    de Pádua Covas Lage, Luís Alberto / Hamasaki, Débora Toshie / Moreira, Frederico Rafael / Rocha, Vanderson / Zerbini, Maria Cláudia Nogueira / Pereira, Juliana

    Annals of hematology

    2019  Volume 98, Issue 9, Page(s) 2097–2102

    Abstract: Nodal peripheral T cell lymphomas (nPTCL) present aggressive clinical course, and its heterogeneous nature and poor prognosis with current therapeutic strategies make it a target for the development of new prognostic markers. Thus, we investigated tumor- ... ...

    Abstract Nodal peripheral T cell lymphomas (nPTCL) present aggressive clinical course, and its heterogeneous nature and poor prognosis with current therapeutic strategies make it a target for the development of new prognostic markers. Thus, we investigated tumor-associated macrophages (TAM) according to the number of cells expressing CD68 in biopsies and the absolute monocyte count (AMC) in peripheral blood of 87 patients with nPTCL. The median overall survival (OS) was 3 years (95% CI 1.3-8.4 years) and estimate 5 years OS of 43.3% (95% CI 32.5-53.7%). The median progression-free survival (PFS) was 1.5 years (95% CI 0.8-2.6 years) with estimate 5 years PFS of 29.2% (95% CI 19.7-39.3%). The cutoff for AMC was 1.5 × 10
    MeSH term(s) Adolescent ; Adult ; Aged ; Aged, 80 and over ; Antigens, CD/blood ; Antigens, Differentiation, Myelomonocytic/blood ; Disease-Free Survival ; Female ; Humans ; Leukocyte Count ; Lymphoma, T-Cell, Peripheral/blood ; Lymphoma, T-Cell, Peripheral/drug therapy ; Lymphoma, T-Cell, Peripheral/mortality ; Lymphoma, T-Cell, Peripheral/pathology ; Male ; Middle Aged ; Monocytes/metabolism ; Monocytes/pathology ; Neoplasm Proteins/blood ; Retrospective Studies ; Survival Rate
    Chemical Substances Antigens, CD ; Antigens, Differentiation, Myelomonocytic ; CD68 antigen, human ; Neoplasm Proteins
    Language English
    Publishing date 2019-06-26
    Publishing country Germany
    Document type Clinical Trial ; Journal Article ; Observational Study
    ZDB-ID 1064950-5
    ISSN 1432-0584 ; 0939-5555 ; 0945-8077
    ISSN (online) 1432-0584
    ISSN 0939-5555 ; 0945-8077
    DOI 10.1007/s00277-019-03731-w
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Adrenal cysts of lymphatic origin: A clinical and pathological study of six cases and systematic literature review.

    Marques-Piubelli, Mario L / Gonzales, Eloiza Wilma Poma / Gonçalves, Victor Lucas / Balancin, Marcelo Luiz / Botelho, Maria Luiza A A / Yamauchi, Fernando Ide / de Mello Ando, Sabrina / Brondani, Vania Balderrama / Chambo, Jose Luis / Fragoso, Maria Candida Barisson Villares / Zerbini, Maria Claudia Nogueira

    Annals of diagnostic pathology

    2022  Volume 57, Page(s) 151888

    Abstract: Adrenal cysts are rare, benign, and usually asymptomatic, being detected as an incidental finding on imaging methods. Adrenal Cysts of Lymphatic Origin (ACLO) and Adrenal Lymphangiomas (AL) are types of endothelial cyst and are the most prevalent subtype ...

    Abstract Adrenal cysts are rare, benign, and usually asymptomatic, being detected as an incidental finding on imaging methods. Adrenal Cysts of Lymphatic Origin (ACLO) and Adrenal Lymphangiomas (AL) are types of endothelial cyst and are the most prevalent subtype in this series. This study aims to present a single institutional experience of these rare cysts and compare their features with those found in the review of existing literature on ACLO and AL. Overall, thirteen cases of adrenal cysts were diagnosed and surgically excised during the study period, onto which we performed immunohistochemistry using a panel of antibodies (CD31, CD34, Pan Cytokeratin AE-1/AE-3, Factor VII, D2-40, and ERG). Four cases of ACLO and two AL were found. The lesions predominantly affected right adrenal, and the majority of patients were middle-age females, of Caucasian ethnicity, and asymptomatic. In our literature review, we found 108 cases of ACLO/AL from 57 articles with similar sex and age distribution. The diagnosis and subclassification of adrenal cysts are challenging, and there is a significant overlapping between the definition of ACLO and AL.
    MeSH term(s) Adrenal Gland Neoplasms/diagnosis ; Adrenal Gland Neoplasms/pathology ; Cysts/pathology ; Female ; Humans ; Immunohistochemistry ; Middle Aged
    Language English
    Publishing date 2022-01-04
    Publishing country United States
    Document type Journal Article ; Systematic Review
    ZDB-ID 1440011-x
    ISSN 1532-8198 ; 1092-9134
    ISSN (online) 1532-8198
    ISSN 1092-9134
    DOI 10.1016/j.anndiagpath.2021.151888
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top